Predictive Value of Positron Emission Tomography/Computed Tomography After ABVD-Based Chemotherapy in Early-Stage...

Carsten Kobe¹, Helen Goergen¹, Michael Fuchs¹+6

• ¹Carsten Kobe, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Helen Goergen, Dipl-Math, Michael Fuchs, MD, and Horst Müller, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Christan Baues, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Andreas Engert, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Markus Dietlein, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; and Bastian von Tresckow, MD and Peter Borchmann, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.